Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 14958

1.

Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.

Koller D, Vaitsekhovich V, Mba C, Steegmann JL, Zubiaur P, Abad-Santos F, Wojnicz A.

Talanta. 2020 Feb 1;208:120450. doi: 10.1016/j.talanta.2019.120450. Epub 2019 Oct 11.

PMID:
31816725
2.

PPARγ Agonists in Combination Cancer Therapies.

Mrowka P, Glodkowska-Mrowka E.

Curr Cancer Drug Targets. 2019 Dec 8. doi: 10.2174/1568009619666191209102015. [Epub ahead of print]

PMID:
31814555
3.

Design, synthesis, biological evaluation and molecular modeling study of new thieno[2,3-d]pyrimidines with anti-proliferative activity on pancreatic cancer cell lines.

Salem MSH, Abdel Aziz YM, Elgawish MS, Said MM, Abouzid KAM.

Bioorg Chem. 2019 Nov 30:103472. doi: 10.1016/j.bioorg.2019.103472. [Epub ahead of print]

PMID:
31813475
4.

Utility of Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis.

García-Ferrer M, Wojnicz A, Mejía G, Koller D, Zubiaur P, Abad-Santos F.

Clin Ther. 2019 Dec 4. pii: S0149-2918(19)30505-3. doi: 10.1016/j.clinthera.2019.10.009. [Epub ahead of print] Review.

PMID:
31812340
5.

Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.

Rosenthal EA, Ho PS, Joe GO, Mitchell SA, Booher S, Pavletic SZ, Baird K, Cowen EW, Comis LE.

Support Care Cancer. 2019 Dec 6. doi: 10.1007/s00520-019-05207-z. [Epub ahead of print]

PMID:
31811481
6.

Meeting the needs of CML patients in resource-poor countries.

Malhotra H, Radich J, Garcia-Gonzalez P.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):433-442. doi: 10.1182/hematology.2019000050.

PMID:
31808889
7.

A rare case of extraluminal gastrointestinal stromal tumor of the ileum presenting with lower urinary tract symptoms: A case report.

Yu CH, Ting HK, Kao CC, Tsai WC, Wu ST, Yu DS.

Medicine (Baltimore). 2019 Dec;98(49):e18103. doi: 10.1097/MD.0000000000018103.

8.

Synthesis, spectroscopic (FT-IR and UV-Vis), crystallographic and theoretical studies, and a molecular docking simulation of an imatinib-like template.

Moreno-Fuquen R, Arango-Daraviña K, Garcia E, Tenorio JC, Ellena J.

Acta Crystallogr C Struct Chem. 2019 Dec 1;75(Pt 12):1681-1689. doi: 10.1107/S2053229619015523. Epub 2019 Nov 26.

PMID:
31802759
9.

Extragastrointestinal stromal tumour (EGIST) presented as a mesenteric and retroperitoneal mass.

Costa Almeida C, Caroço TV, Albano M, Carvalho L.

BMJ Case Rep. 2019 Dec 2;12(12). pii: e232481. doi: 10.1136/bcr-2019-232481.

PMID:
31796439
10.

Automated osteosclerosis grading of clinical biopsies using infrared spectroscopic imaging.

Mankar R, Bueso-Ramos CE, Yin CC, Hidalgo Lopez JEE, Berisha S, Kansiz M, Mayerich D.

Anal Chem. 2019 Dec 2. doi: 10.1021/acs.analchem.9b03015. [Epub ahead of print]

PMID:
31793292
11.

A Novel Series of Chlorinated Plastoquinone Analogs: Design, Synthesis, and Evaluation of Anticancer Activity.

Bayrak N, Yıldırım H, Yıldız M, Radwan MO, Otsuka M, Fujita M, Ciftci HI, Tuyun AF.

Chem Biol Drug Des. 2019 Nov 30. doi: 10.1111/cbdd.13651. [Epub ahead of print]

PMID:
31785034
12.

A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.

Marangon E, Buzzo M, Posocco B, Gagno S, Zanchetta M, Iacuzzi V, Poetto AS, Guardascione M, Giodini L, Toffoli G.

J Pharm Biomed Anal. 2019 Oct 25:112949. doi: 10.1016/j.jpba.2019.112949. [Epub ahead of print]

PMID:
31784210
13.

Imatinib, sunitinib and pazopanib: from flat-fixed dosing towards a pharmacokinetically guided personalized dose.

Westerdijk K, Desar IME, Steeghs N, van der Graaf WTA, van Erp NP; Dutch Pharmacology and Oncology Group (DPOG).

Br J Clin Pharmacol. 2019 Nov 28. doi: 10.1111/bcp.14185. [Epub ahead of print] Review.

PMID:
31782166
14.

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours.

Huang M, Yang W, Zhu J, Mariño-Enríquez A, Zhu C, Chen J, Wu Y, Quan Y, Qiu H, Li X, Chai L, Fletcher JA, Ou WB.

Br J Cancer. 2019 Nov 28. doi: 10.1038/s41416-019-0657-5. [Epub ahead of print]

PMID:
31776458
15.

Endoscopic Removal of Gastrointestinal Stromal Tumors in the Stomach: A Single-Center Experience.

Guo Y, Jing X, Zhang J, Ding X, Li X, Mao T, Tian Z.

Gastroenterol Res Pract. 2019 Oct 22;2019:3087298. doi: 10.1155/2019/3087298. eCollection 2019.

16.

Adverse effects of dasatinib on glucose-lipid metabolism in patients with chronic myeloid leukaemia in the chronic phase.

Yu L, Liu J, Huang X, Jiang Q.

Sci Rep. 2019 Nov 26;9(1):17601. doi: 10.1038/s41598-019-54033-0.

17.

Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension.

Nakamura K, Akagi S, Ejiri K, Yoshida M, Miyoshi T, Toh N, Nakagawa K, Takaya Y, Matsubara H, Ito H.

Int J Mol Sci. 2019 Nov 23;20(23). pii: E5885. doi: 10.3390/ijms20235885. Review.

18.

Huge Gastrointestinal Stromal Tumor of the Jejunum Presenting as Bowel Obstruction: A Rare Presentation.

Huda T, Singh MP.

Gastrointest Tumors. 2019 Oct;6(3-4):116-121. doi: 10.1159/000501744. Epub 2019 Aug 20.

PMID:
31768355
19.

Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia.

Rabian F, Lengline E, Rea D.

Curr Hematol Malig Rep. 2019 Nov 23. doi: 10.1007/s11899-019-00546-4. [Epub ahead of print] Review.

PMID:
31760572
20.

Association between C1236T Genetic Variant of ABCB1 Gene and Molecular Response to Imatinib in Indonesian Chronic Myeloid Patients.

Rinaldi I, Nova R, Widyastuti R, Priambodo R, Instiaty I, Louisa M.

Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3331-3334. doi: 10.31557/APJCP.2019.20.11.3331.

Supplemental Content

Loading ...
Support Center